Themis Medicare Ltd

Themis Medicare Ltd share price declined by 4.73% to Rs 107.65. The Company's net profit saw a strong growth of 176.83% to Rs 24.61 crore, while revenue from operations gained 13.63% to Rs 86.96 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, gaining 4.61%. It has marginally improved by 0.97% over last one week and heading higher by 11.17% in last one month while the market capitalization of Themis Medicare Ltd has softened by 4.44% and 9.91% in the same period respectively. Profit before tax (PBT) of Themis Medicare Ltd stood at Rs 38.6 crore in Q2 FY26, tanking 374.54% year-on-year, and jumping 326.05% quarter-on-quarter. EBITDA came in at Rs 53 crore, surging by 374.33% YoY and tumbling by 59444.44% sequentially. Total expenses witnessed a sharp rise of 88.30% to Rs 141.92 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 17.63 crore, witnessing a sharp rise of 23.55% YoY, while employee benefits expense was at Rs 22.18 crore, inching up 5.32% YoY. For the TTM ended FY26, revenue from operations inched higher 6.22% to Rs 405.51 crore, while net profit plunged by 31.46% to Rs 29.83 crore, compared to previous TTM. EBITDA surged by 4343% to Rs 44.38 crore, and PBT collapsed by 25.77% to Rs 39.67 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 34.71 crore in FY26, as against Rs 22.09 crore in FY25. Themis Medicare Ltd gained 1.27% in last one year, outperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.

Themis Medicare Limited will hold a board meeting on Thursday, August 13, 2026, to approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, along with the statutory auditors’ limited review reports, according to a filing with the BSE Limited and National Stock Exchange of India Limited. The company had previously closed its trading window for designated persons from July 1, 2026, until 48 hours after the financial results are published, in compliance with SEBI regulations.

Vividhmargi Investments Private Limited has disclosed pledging 30,00,000 equity shares of Themis Medicare Limited on July 30, 2026, according to a filing with the BSE Limited and National Stock Exchange of India Limited. The pledge, representing 3.26% of the total share capital, was created against borrowing in favor of CTL Trusteeship Limited (Trustee) for Kotak Credit Opportunities Fund – Kotak Credit Opportunities Fund (Lender). Vividhmargi Investments Private Limited currently holds 2,44,29,460 shares, representing 26.52% of Themis Medicare Limited’s share capital.

Net profit of Themis Medicare reported to Rs 8.89 crore in the quarter ended March 2026 as against net loss of Rs 9.66 crore during the previous quarter ended March 2025. Sales rose 6.74% to Rs 76.53 crore in the quarter ended March 2026 as against Rs 71.70 crore during the previous quarter ended March 2025. For the full year,net profit declined 96.18% to Rs 1.14 crore in the year ended March 2026 as against Rs 29.83 crore during the previous year ended March 2025. Sales declined 15.60% to Rs 342.24 crore in the year ended March 2026 as against Rs 405.51 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales76.5371.70 7 342.24405.51 -16 OPM %4.91-10.73 -0.1212.10 - PBDT11.66-8.60 LP 13.1249.60 -74 PBT9.06-11.13 LP 2.8039.67 -93 NP8.89-9.66 LP 1.1429.83 -96 Powered by Capital Market - Live

Themis Medicare announced that the Board of Directors of the Company at its meeting held on 28 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

Themis Medicare will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live

Net loss of Themis Medicare reported to Rs 3.62 crore in the quarter ended September 2025 as against net profit of Rs 14.29 crore during the previous quarter ended September 2024. Sales declined 33.35% to Rs 77.99 crore in the quarter ended September 2025 as against Rs 117.01 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales77.99117.01 -33 OPM %-3.9614.64 - PBDT-0.8820.25 PL PBT-3.4517.80 PL NP-3.6214.29 PL Powered by Capital Market - Live

Net loss of Themis Medicare reported to Rs 5.36 crore in the quarter ended September 2025 as against net profit of Rs 9.87 crore during the previous quarter ended September 2024. Sales declined 33.35% to Rs 77.99 crore in the quarter ended September 2025 as against Rs 117.01 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales77.99117.01 -33 OPM %-3.9914.63 - PBDT-2.6315.82 PL PBT-5.2013.37 PL NP-5.369.87 PL Powered by Capital Market - Live

Themis Medicare will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

Consolidated Construction Consortium Ltd, Sigachi Industries Ltd, Lambodhara Textiles Ltd and Punjab Chemicals & Crop Protection Ltd are among the other gainers in the BSE's 'B' group today, 12 September 2025.Themis Medicare Ltd spiked 20.00% to Rs 122.72 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.06 lakh shares were traded on the counter so far as against the average daily volumes of 4954 shares in the past one month. Consolidated Construction Consortium Ltd surged 18.45% to Rs 21.96. The stock was the second biggest gainer in 'B' group. On the BSE, 17.57 lakh shares were traded on the counter so far as against the average daily volumes of 2.69 lakh shares in the past one month. Sigachi Industries Ltd soared 12.81% to Rs 42.61. The stock was the third biggest gainer in 'B' group. On the BSE, 195.68 lakh shares were traded on the counter so far as against the average daily volumes of 9.1 lakh shares in the past one month. Lambodhara Textiles Ltd rose 12.17% to Rs 141.5. The stock was the fourth biggest gainer in 'B' group. On the BSE, 12426 shares were traded on the counter so far as against the average daily volumes of 1438 shares in the past one month. Punjab Chemicals & Crop Protection Ltd gained 10.85% to Rs 1257.6. The stock was the fifth biggest gainer in 'B' group. On the BSE, 54632 shares were traded on the counter so far as against the average daily volumes of 1770 shares in the past one month. Powered by Capital Market - Live